Search - tctmd.com

Displaying 61 - 80 of 867

Sort: Relevancy | Date

News Conference News EACTS 2025

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

Yael L. Maxwell

October 13, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Conference News ESC 2025

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Caitlin E. Cox

September 08, 2025

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Opinion Editor's Corner

TCTMD's Top 10 Most Popular Stories for August 2025

Caitlin E. Cox

August 28, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

Presentation NY Valves 2025

One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement

Presenter: Isaac George

June 27, 2025

Presentation NY Valves 2025

Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies

Presenter: Guido Ascione

June 27, 2025

Presentation NY Valves 2025

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Presenter: Santiago Garcia

June 27, 2025

Presentation NY Valves 2025

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

Presenter: Gilbert H. L. Tang

June 27, 2025

Presentation NY Valves 2025

Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries

Presenter: Julio Echarte Morales

June 26, 2025

Presentation NY Valves 2025

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Presenter: Suzanne V. Arnold

June 26, 2025

Presentation NY Valves 2025

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Presenter: Paul A. Grayburn

June 26, 2025

Presentation NY Valves 2025

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Presenter: Matthew J. Price

June 26, 2025

Presentation NY Valves 2025

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

Presenter: Santiago Garcia

June 25, 2025

Presentation NY Valves 2025

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Presenter: Shinichi Fukuhara

June 25, 2025

Presentation NY Valves 2025

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Presenter: Sammy Elmariah

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

Advertisement

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

What’s Going to Be Hot at TCT 2025

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

TCTMD's Top 10 Most Popular Stories for August 2025

What’s Going to Be Hot at ESC Congress 2025?

One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement

Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content